For comparison, ELISA assay was performed on protein content extracted from plasma-derived exosomes of the same healthy and NAFLD-affected subjects to quantitatively evaluate the FZD7 concentration (expressed in ng/mL) and assess the validity of the analytical method (Figure 2C). The gene discussed is FZD7; the disease is metabolic dysfunction-associated steatotic liver disease.